JACOB MANDEL to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications JACOB MANDEL has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.430
-
Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
Score: 0.321
-
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
Score: 0.080
-
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol. 2020 04 15; 22(4):539-549.
Score: 0.030